Mark J Shelton Selected Research

Delavirdine (Rescriptor)

1/2003	Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients.
1/2003	Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark J Shelton Research Topics

Disease

4	Infections 02/2008 - 01/2003
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2015
1	Breast Neoplasms (Breast Cancer) 03/2015
1	Human Influenza (Influenza) 11/2011
1	Tuberculosis (Tuberculoses) 02/2008
1	Drug-Related Side Effects and Adverse Reactions 02/2007
1	HIV Infections (HIV Infection) 01/2003

Drug/Important Bio-Agent (IBA)

2	Delavirdine (Rescriptor)FDA Link 01/2003 - 01/2003
1	Imatinib Mesylate (Gleevec)FDA Link 10/2022
1	ripretinibIBA 10/2022
1	Phosphotransferases (Kinase)IBA 10/2022
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	eribulin FDA Link 03/2015
1	Pemetrexed (MTA)FDA Link 03/2015
1	Zanamivir (Relenza)FDA Link 11/2011
1	Rifabutin (Ansamycin)FDA Link 02/2008
1	fosamprenavir (Lexiva)FDA Link 02/2007
1	Triglycerides (Triacylglycerol)IBA 02/2007
1	Ritonavir (Norvir)FDA Link 02/2007
1	Reverse Transcriptase InhibitorsIBA 01/2003
1	NucleosidesIBA 01/2003

Therapy/Procedure

1	Therapeutics 03/2015